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548 The Journal of Thoracic and Cardbjective: Any grade of ischemic mitral regurgitation is associated with excess
ortality. Whether mild ischemic mitral regurgitation should be repaired at the time
f either coronary artery bypass grafting or surgical ventricular restoration is
ontroversial. Surgical ventricular restoration is a treatment option for dilated
ost-infarction cardiomyopathy and has the potential to improve mitral functioning.
he present study assessed the effectiveness of surgical ventricular restoration and
nrepaired mild ischemic mitral regurgitation on left ventricular geometry, cardiac
nd functional status, and survival.
ethods: We analyzed 55 patients with previous anterior infarction (age 65  10
ears) and mild chronic functional mitral regurgitation who underwent surgical
entricular restoration and coronary artery bypass grafting without mitral repair at
ur center. Left ventricular volumes, ejection fraction, and geometric parameters
ere measured before and after surgery.
esults: Even mild ischemic mitral regurgitation is characterized by abnormal left
entricular geometry when compared with that of patients without mitral regurgi-
ation at comparable ventricular volumes and ejection fraction. Surgical ventricular
estoration induces a significant decrease in left ventricular volumes, left ventricular
iameters, and papillary muscle distance; and an improvement in ejection fraction
nd New York Heart Association class. Ischemic mitral regurgitation significantly
ecreases in the majority of patients. Survival is 93% at 1 year and 88% at 3 years.
onclusion: Surgical ventricular restoration improves mitral functioning by improv-
ng geometry abnormalities. Survival is optimal and greater than would be expected
n patients with post-infarction dilated ventricles and depressed left ventricular
unction. Our data indicate that mitral repair in conjunction with surgical ventricular
estoration is unnecessary in such patients.
schemic mitral regurgitation (IMR) is frequently associated with dilated post-
infarction cardiomyopathy and indicates a poor survival, even when mi1,2
Surgical ventricular restoration (SVR) aims to restore normal left ventricular
LV) geometry and function and includes complete coronary revascularization,
entricular reconstruction, and mitral repair when needed.3-7 Although there i
eneral agreement that IMR should be treated surgically when it is moderate to
evere, there is no consensus if, how, and when mild IMR should be repaired in
onjunction with SVR. SVR has 3 important objectives to alter functional mitral
egurgitation (MR); these are directed toward the vessel, ventricle, and valve, and
herefore has the potential of improving mitral valve functioning by reducing LV
olume, reapproaching papillary muscles, and rebuilding a more normal geome-
ry.8-11 Some authors recommend treating the mitral valve in conjunction 
VR,9,12 but data on the natural history and surgical results are limited.
iovascular Surgery ● December 2007
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Di Donato Surgery for Acquired Cardiovascular Disease
A
CDThe objective of the present study was to assess the
ffectiveness of SVR in patients with unrepaired mild IMR
ho underwent surgery for dilated ischemic cardiomyopa-
hy caused by anterior infarction. To define geometric char-
cteristics in terms of sphericity, annular size, and papillary
uscle width, we used comparisons in patients with anterior
nfarction but without MR.
aterials and Methods
atient Selection
rom July of 2001 to December of 2006, 309 consecutive patients
ith previous anterior myocardial infarction and symptoms of
eart failure, angina, or a combination of the two underwent SVR
t our center. Clinical, demographic, and echocardiographic data
ere prospectively gathered and stored on a customized database
hat had been approved by our local ethical committee. In our
atients, we elect to repair the mitral valve in conjunction with
VR when IMR is moderate to severe (grade 3-4) and in mild
MR (grade 2) when the mitral annulus is dilated (40 mm).
mong 64 patients with grade 2 IMR, 55 did not undergo repair
nd they represent our study group.
All patients had complete transthoracic echocardiograms be-
ore surgery and at discharge (8–10 days after surgery). To define
eometric characteristics in sphericity, annular size, and papillary
uscle width, we used comparisons in 67 patients (aged 65  9
ears, 11 female) with anterior infarction but without MR. Cardiac
perative mortality was defined as death from cardiac causes
ccurring within 30 days from surgery; long-term mortality in-
ludes death from any cause.
chocardiographic Studies
wo-dimensional, M-mode, and color Doppler transthoracic echo-
ardiography was performed using a GE Vivid 7 (GE Healthcare,
aukesha, Wis) echocardiographic instrument, and all 4-chamber,
-chamber, long-axis, and short-axis views were analyzed before
nd after surgery in all patients. The parameters measured included
he following:
● Diastolic and systolic internal diameters in parasternal long-
axis view (millimeters)
● End-diastolic and end-systolic volume calculated by apply-
ing the Simpson method (milliliters)
● Ejection fraction (EF) derived from volumes as end-diastolic
volume – end-systolic volume/end-diastolic volume (%)
● Mitral annulus dimension defined as the distance between
the hinge points of the anterior and posterior mitral leaflets
Abbreviations and Acronyms
CABG coronary artery bypass grafting
EF  ejection fraction
ERO  effective regurgitant orifice
IMR  ischemic mitral regurgitation
LV  left ventricular
MR mitral regurgitation
SVR  surgical ventricular restorationin long-axis view (millimeters) p
The Journal of Thoracic● Papillary muscle distance in short-axis view defined as the
distance between the 2 papillary muscle heads (millimeters)
● Long axis measured in 4-chamber view as the distance
between the apex and the mitral plane (millimeters)
● Short axis measured in 4-chamber view at the midlevel of
the long axis (millimeter)
● Sphericity index calculated as the short- to long-axis ratio, in
diastole and systole
In our daily clinical activity, we assess the degree of MR in a
emiquantitative way using the following scale: 0  absent, 1 
rivial, 2  mild, 3  moderate, and 4  severe.
atient Characteristics
here were 9 women and 46 men with a mean age of 65  10
ears. All had grade 2 MR; 29 patients had New York Heart
ssociation class 3 or 4; 30 patients had a preoperative EF less
han 35%.
urgical Technique
he details of the surgical technique have been reported.4,5,7,8,10
riefly, the procedure is conducted on the arrested heart with
ntegrade crystalloid or blood cold cardioplegia. Complete coro-
ary artery revascularization is first performed, almost always with
he left internal thoracic artery on the left anterior descending
rtery and sequential venous grafts on the right and circumflex
rteries, when needed. After completion of coronary grafting, the
eft ventricle is opened with an incision parallel to the left anterior
escending artery, extending from the apex to the middle scarred
egion. The ventricular cavity is inspected, and thrombi are re-
oved if they are present. Each papillary muscle head is identified,
nd the mitral valve leaflets and chords are evaluated. SVR is
erformed using a mannequin (TRISVR, Chase Medical, Richard-
on, Tex) filled at 50 to 60 mL/m2 to optimize the size and shape
f the new ventricle.
esults
ll patients underwent SVR, and all patients except 2 had
oncomitant coronary artery bypass grafting (CABG). The
ean number of distal anastomosis was 2.9  1.4; preop-
rative patient characteristics and medications are summa-
ized in Table 1. The operative cardiac mortality was 
4/55). Univariate analysis showed that patients who died
ad significantly lower EF (27%  8% vs 35%  7%;
 .009), thinner interventricular septum (9  2.0 mm vs
1  2.8 mm; P  .01), greater QRS (138  26 msec vs
12  27 msec; P  .01), and greater pulmonary pressure
47  11 mm Hg vs 35  9 mm Hg; P  .02). The cause
f operative mortality was low cardiac output in all patients.
able 2 shows the operative data and early postoper
omplications.
Table 3 shows the baseline geometric measurements
atients with MR compared with patients without MR.
olumes and EF are not significantly different; geometric
easurements are significantly abnormal with respect toatients without MR. This finding indicates that geometric
and Cardiovascular Surgery ● Volume 134, Number 6 1549
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1
A
CDbnormalities, and not volume increase, are major determi-
ants of MR in patients with anterior infarction.
arly Functional and Geometric Changes Induced
y Surgical Ventricular Restoration
ransthoracic echocardiography performed at discharge
8–10 days after surgery) was used for all postoperative
easurements. The results are shown in Table 4. There
ignificant reduction in dimensions and volumes, both in
iastole and systole, an improvement in EF, a reduction in
apillary muscle distance, and no change in mitral annulus
r sphericity index.
The average degree of MR after surgery was 1  0.8; it
as unchanged in 12 patients, improved in 36 patients, and
ncreased to grade 3 in 3 patients (Figure 1). Patie
ithout improved MR after SVR had significantly greater
iastolic and systolic diameters preoperatively and postop-
rative; both volumes and diameters were greater compared
ith those of patients with improved mitral functioning
Table 5). We could not determine a cutoff value of dia
r systolic LV dimensions predictive of lack of improve-
ent in mitral functioning or adverse events; however, if the
iastolic internal diameter or the short axis exceeds 65 mm,
t is unlikely that MR can improve without concomitant
ABLE 1. Preoperative patient characteristics and medi-
ations (n  55)
n (%)
ale/female 46/9
ge 65 10
iabetes 17 (31)
mpaired renal function 7 (13)
trial fibrillation 7 (13)
erebrovascular events 4 (7)
revious PTCA 6 (11)
revious CABG 2 (4)
revious ICD 4 (7)
ngina 40 (75)
nstable 10 (18)
YHA class III/IV 29 (53)
urrent medications
ACEIs 45 (82)
Beta-blockers 34 (62)
Aspirin 47 (84)
Warfarin 3 (5)
Diuretics 36 (65)
Nitrates 29 (53)
Statins 23 (42)
Digoxin 2 (4)
TCA, Percutaneous transluminal coronary angiography; CABG, coronary
rtery bypass grafting; ICD, implantable cardioverter defibrillator; NYHA,
ew York Heart Association; ACEI, angiotensin-converting enzyme
nhibitor.itral surgery. W
550 The Journal of Thoracic and Cardiovascular Surgery ● Deca
c
ate Findings
ew York Heart Association class improved from 2.5 0.7
o 1.4  0.5 (P  .0001). Twenty patients had a new echo
valuation late after surgery (mean time from surgery was
2 months, minimum of 4 months and maximum of 37
onths). Seven patients had no or trivial MR, 10 patients
ad grade 2 MR, and 3 patients had grade 3 MR.
Follow-up was 100% complete. Mean follow-up was
5  13 months. There were 10 hospital readmissions
uring the entire follow-up: 3 for heart failure, 1 for a
ransitory ischemic attack, 3 for noncardiac causes, and 1
or arrhythmia. One patient received an implantable cardio-
erter defibrillator, and 1 patient received an implantable
ardioverter defibrillator plus cardiac resynchronization
herapy. One patient died of a noncardiac cause at 28
onths. The actuarial survival curve, including operative
ortality, is shown in Figure 2. Overall survival, inclu
arly mortality, was 93% at 1 year and 88% at 3 years.
iscussion
he objective of this study was to assess the effectiveness of
VR in patients undergoing SVR and unrepaired mild isch-
mic MR. To ensure a homogeneous series of patients, we
pecifically studied the impact of mild MR after anterior
yocardial infarction because the underlying ischemic dis-
ase does not directly affect the papillary muscles, leaflets,
hords, or annulus, and MR is consequently related com-
letely to LV remodeling. In previous articles,4.10 we re-
orted that any degree of MR in anterior infarction resulted
n 1) worsening of clinical and hemodynamic parameters, 2)
hape and function abnormalities in remote inferior wall,
nd 3) worsening in volume and geometry in untreated MR.
ABLE 2. Operative data and early postoperative compli-
ations
n %
ultivessel CAD 41 74
ABG 53 96
TA/LAD 51 93
istal anastomosis 2.9 1.4
omplications
Bleeding 1 2.6
Infections 7 13
Renal failure 2 3.6
IABP 5 9
TIA 2 3.6
VA 4 7
AF 7 12.7
AD, Coronary artery disease; CABG, coronary artery bypass grafting; ITA,
nternal thoracic artery; LAD, left anterior descending artery; IABP, intra-
ortic balloon pumping; TIA, transitory ischemic attack; VA, ventricular
rrhythmias; AF, atrial fibrillation.e also speculated that it might be unwise to leave any
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A
CDunctional MR in large ventricles with a wide transverse
iameter and hoped that future studies would test the con-
ept. Data on the natural history of functional MR are
imited, but several observational studies showed that MR
as an independent association with a poor prognosis.
schemic Mitral Regurgitation
clear definition of IMR is lacking, and different descrip-
ors have resulted in heterogeneous patient groups, which in
urn complicate comparisons between studies.3
In ischemic MR, the mitral leaflets are normal and MR is
aused by deformation of subvalvular mitral apparatus as
he result of LV remodeling. Echocardiographic character-
stics of ischemic MR include low mitral leaflet coaptation
nd anterior and posterior leaflet tethering causing restric-
ion of mitral leaflets with or without concomitant wall
otion abnormalities, particularly at the posterolateral
all.13 LV distortion and remodeling after an anterior -
arction displace papillary muscle toward the apex, resulting
n apical mitral tethering and restriction of coaptation during
ABLE 3. Baseline geometric measurements in mitral regu
ation
No MR (n 
iastolic diameter (mm) 58 9
ystolic diameter (mm) 46 10
nd-diastolic volume (mL) 191 51
nd-systolic volume (mL) 127 44
F (%) 34 9
itral annulus (mm) 30 4
iastolic short axis (mm) 49 8
ystolic short axis (mm) 38 9
apillary muscle dist (mm) Diastole 24 8
phericity index (diastole) 0.48 0.
phericity index (systole) 0.40 0.
R, Mitral regurgitation; EF, ejection fraction; NS, not significant.
ABLE 4. Preoperative and postoperative data in patients
ith mitral regurgitation
Preoperative Postoperative P
iastolic diameter (mm) 64 8 61  9 .007
ystolic diameter (mm) 52 11 48  9 .01
nd-diastolic volume (mL) 201 69 150  49 .0001
nd-systolic volume (mL) 137 60 94 39 .0001
F (%) 34 8 41  8 .0001
itral annulus (mm) 34 4 33  7 NS
iastolic short axis (mm) 54 8 49  6 .0005
ystolic short axis (mm) 47 8 42  8 .001
apillary muscle dist (mm) (D) 28 5 25  7 .02
phericity index (diastole) 0.56 0.09 0.58  0.08 NS
phericity index (systole) 0.47 0.01 0.51  0.14 NSSF, Ejection fraction; NS, not significant.
The Journal of Thoracicystole; the reduced contractile function decreases the clos-
ng forces on the leaflets.14-19 The MR jet is usually centr
nd the severity is often mild. In these patients, conservative
anagement is associated with poor prognosis with a 1-year
urvival of 30% to 40%.20 The excess mortality is indepe-
ent of baseline characteristics and degree of ventricular
ysfunction; the effective regurgitant orifice (ERO) was the
nly independent predictor of mortality.1 An ERO less tha
r equal to 20 mm2 identifies mild MR, but despite its
egative impact on survival there is no consensus on
hether and when to intervene in mild MR in patients who
re undergoing CABG alone or associated with SVR. A
tudy in patients undergoing isolated CABG without severe
MR reported that the presence of moderate IMR, and even
ild IMR, was associated with decreased survival.21 SVR
as the potential of improving mitral functioning, but there
re limited data on the effectiveness of SVR on unrepaired
MR.
igure 1. Changes induced by SVR in mitral functioning. SVR,
tion grade 2 compared with those in no mitral regurgi-
MR grade 2 (n  55) P
64  8 .009
52 11 .01
201 69 NS
137 60 NS
34  8 NS
34  4 .02
54  8 .05
47  8 .003
28  5 .02
0.56 0.09 .003
0.47 0.01 .03rgita
67)
08
09urgical ventricular restoration.
and Cardiovascular Surgery ● Volume 134, Number 6 1551
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1
A
CDIt is generally accepted that moderate to severe MR
grade 3-4) is an indication for surgical repair in conjunc-
ion with SVR, and it has been reported that adding mitral
epair to SVR  CABG and to CABG alone increases the
perative risk because of the prolonged surgical time, tech-
ical complexity, and patient selection.3,22-24 In our expe-
ience we elect to repair the mitral valve through a ventric-
lotomy with a posterior suture during SVR, when the
egree of MR is moderate or severe (grade 3-4), and, if
he degree is mild, we perform mitral repair if the annulus
s markedly dilated (40 mm). In our series we found 9
atients with grade 2 MR and annular dilatation greater than
0 mm who had mitral repair. Such a small number pre-
ludes any comment on this peculiar subset of patients. A
ecent article by Sartipy and colleagues23 confirmed a
igher operative mortality (16%) in patients with mild-to-
evere MR undergoing mitral repair in conjunction with
VR, and survival in these patients was significantly worse
han in patients undergoing SVR without mitral repair. In
he series by Sartipy and coworkers, the degree of repaired
R was mild (2) in the majority of patients (18/31), and
hey used the same semiquantitative assessment of MR as
e did. Our results, showing an optimal midterm survival
igure 2. Survival curve after SVR in patients with unrepaired
ild ischemic MR. SVR, Surgical ventricular restoration; MR,
ABLE 5. Patient characteristics by surgical ventricular re
Preoperative Data
DD SD EDV
R improved N  36 61 9 46  10 199  84 137
R not improved N  15 67  6 53  7 209  55 142
.03 .03 NS
D, Diastolic diameter (mm); SD, systolic diameter (mm); EDV, end-diastoli
ignificant; MR, mitral regurgitation.aitral regurgitation.
552 The Journal of Thoracic and Cardiovascular Surgery ● Decnd an acceptable operative risk in patients with dilated
entricles, reduced LV function, and unrepaired mild MR,
uggest that mitral repair in conjunction with SVR is un-
ecessary in such patients. Survival in our patient popula-
ion is higher than that expected in the natural history of
atients postinfarction with chronic IMR.1,2
eft Ventricular Geometry in Patients With Ischemic
itral Regurgitation and Effectiveness of Surgical
entricular Restoration
R in organic mitral disease is considered severe when the
RO is greater than 40 mm2, but in functional ischemic MR a
ower threshold of regurgitant orifice (ERO 20) is sufficient
o diagnose severe MR because of its association with poor
rognosis.1,3 In our patients with mild MR, LV volumes
arge, EF is depressed, and geometry is abnormal. SVR im-
roves geometry and function and reduces the degree of MR in
he majority of patients. Patients without improved mitral func-
ioning have larger transverse diameters preoperatively, and
espite SVR reduction, MR does not improve. A larger pop-
lation is needed to find predictors of lack of mitral improve-
ent. However, the residual mild MR (only 3 patients with
rade 3) does not seem to affect New York Heart Associa-
ion class improvement or survival.
Our data confirm that IMR is a ventricle and not a valve
athologic condition. The reconstruction of the ventricle
eads to a better functioning of the mitral valve by reducing
apillary muscle distance (which is a main determinant of
unctional MR) and LV volumes. Sphericity does not
hange significantly, and this is because of the greater
eduction of the long axis with respect to the short axis,
espite the use of the shaper device that helps to maintain a
ore normal short- to long-axis ratio. The improvement in
ardiac and functional status and in mitral functioning led to
n optimal survival in our series of patients.
imitations
he major limitation is that this study is observational and
ot randomized. We report the results from our clinical
rogram and did not include an appropriate control group of
atients who underwent the mitral procedure, because we
ave only 9 such patients and cannot draw any conclusions
ation–induced changes in mitral functioning
Postoperative Data
EF DD SD EDV ESV EF
8 34  8 54  7 43  8 120  31 70  23 42  8
5 33  6 61  6 50  7 140  43 86  27 39  5
NS .003 .01 .05 .04 NS
me (mL); ESV, end-systolic volume (mL); EF, ejection fraction (%); NS, notstor
ESV
 7
 4
NS
c volut present. Survival in our population is good if we consider
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Di Donato Surgery for Acquired Cardiovascular Disease
A
CDhat worsening heart failure symptoms and a poor prognosis
ould be expected for such patients.24-27 Another limitation
s that the severity of MR was estimated in a semiquantita-
ive way by color Doppler 2-dimensional echo technique,
hich is the most common MR evaluation obtained in a
ardiac surgery setting. Finally, mitral assessment late after
urgery is limited and not protocol driven.
onclusions
ur study shows that SVR associated with complete coro-
ary revascularization in the setting of modest LV dysfunc-
ion, dilated ventricles, and mild MR improves mitral func-
ioning, at least initially, by correcting the abnormal LV
eometry and relieving ischemia. The rate of hospital read-
ission is low; only 2 patients required implantable cardio-
erter defibrillator and cardiac resynchronization therapy
ost SVR. Midterm survival is optimal and considerably
igher than that reported in patients after myocardial infarc-
ion with any grade of IMR.
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